Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Apr 2026 for NEUROONE MEDICAL TECHNOLOGIES Corp. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Edward Andrle: trading record in brief
This profile gathers the share dealings of Edward Andrle in NEUROONE MEDICAL TECHNOLOGIES Corp, where the filings describe the role as board member. The record holds 5 filings, for trades running from 2 June 2021 to 3 April 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 7 April 2026, the filings show a share grant in NEUROONE MEDICAL TECHNOLOGIES Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Edward Andrle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
41,929 shares0Common StockSEC:0001656026-26-000003:0
27,778 shares0Common StockSEC:0001656026-25-000001:0
20,576 shares0Common StockSEC:0001656026-23-000001:0
29,240 shares0Common StockSEC:0001656026-22-000001:0
4,592 shares0Common StockSEC:0001596771-21-000037:0
5 of 5 declarations
